Log In Get Started

Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

12,272 total articles

CETY Partnership With Sagacity Yields Success in Design and Manufacture of Advanced ORC Components, Significantly Reducing System Costs and Strengthening Supply Chain Efficiency
Jun 15, 2026
Maya Rios
Press Releases

CETY Partnership With Sagacity Yields Success in Design and Manufacture of Advanced ORC Components, Significantly Reducing System Costs and Strengthening Supply Chain Efficiency

Clean Energy Technologies, Inc. (CETY) announces successful progress in a manufacturing partnership with Sagacity, leading to reduced costs and improved supply chain efficiency for their Organic Rankine Cycle (ORC) waste heat recovery systems. This initiative supports scalable production and broader adoption of their clean energy technology across …

CETY
LPL Financial Welcomes Fortress Financial Planning
Jun 15, 2026
Caleb Monroe
Press Releases

LPL Financial Welcomes Fortress Financial Planning

LPL Financial announced that advisors from Fortress Financial Planning have joined its broker-dealer and Registered Investment Advisor platform, bringing approximately $150 million in assets. The move reinforces LPL's position as a leading wealth management firm supporting independent financial advisors with flexible and personalized service offeri…

LPLA
ENDO 2026 Oral Presentation Highlights Comparative Clinical Data for Entera’s Breakthrough Single Tablet EB613 (First-in-Class Oral PTH(1-34) Anabolic for Osteoporosis)
Jun 15, 2026
Nina Shah
Press Releases

ENDO 2026 Oral Presentation Highlights Comparative Clinical Data for Entera’s Breakthrough Single Tablet EB613 (First-in-Class Oral PTH(1-34) Anabolic for Osteoporosis)

Entera Bio Ltd. presented encouraging Phase 1 clinical data at ENDO 2026 demonstrating that their single tablet oral anabolic therapy, EB613, achieved pharmacokinetic and pharmacodynamic profiles comparable to the injectable standard treatment Forteo4. EB613 was well-tolerated with a favorable safety profile and was preferred by study participants…

ENTX
Wearable Devices to Unveil GenAI-Powered Intent-Based Interface Platform and Next-Gen Mudra Pro Flagship at AWE 2026
Jun 15, 2026
Caleb Monroe
Press Releases

Wearable Devices to Unveil GenAI-Powered Intent-Based Interface Platform and Next-Gen Mudra Pro Flagship at AWE 2026

Wearable Devices Ltd. announced its showcasing of a comprehensive neural input ecosystem at the Augmented World Expo 2026, highlighting its next-generation Mudra Pro hardware platform and Mudra Studio software platform leveraging generative AI. These innovations enable ultra-low latency, touchless, gesture-based controls for AI, augmented reality, …

WLDS
BlockchAIn Announces Corporate Name Change to AIB Data Centers Inc.
Jun 15, 2026
Avery Klein
Press Releases

BlockchAIn Announces Corporate Name Change to AIB Data Centers Inc.

BlockchAIn Digital Infrastructure, trading as AIB on NYSE American, announced a corporate name change to AIB Data Centers Inc. reflecting its strategic pivot from digital asset infrastructure to AI and high-performance computing data center development and operations. The name change will be effective June 25, 2026, with trading under the new name …

AIB
Fate Therapeutics Appoints Laura Hamill to Board of Directors
Jun 15, 2026
Sofia Navarro
Press Releases

Fate Therapeutics Appoints Laura Hamill to Board of Directors

Fate Therapeutics appoints Laura Hamill, a seasoned global biopharma executive with extensive commercial and strategic experience, to its Board as it advances its iPSC-derived cellular immunotherapy pipeline towards later-stage clinical development and commercialization. This move is expected to bolster the company's transition to a commercial-stag…

FATE
RBB Bancorp Announces Authorized Common Stock Repurchase Plan and Partial Redemption of Subordinated Debt
Jun 15, 2026
Derek Hwang
Press Releases

RBB Bancorp Announces Authorized Common Stock Repurchase Plan and Partial Redemption of Subordinated Debt

RBB Bancorp announced that its board authorized a stock repurchase plan to buy back up to 1 million shares, approximately $25 million or 6% of outstanding shares, through June 30, 2028. Concurrently, the company plans to redeem $40 million of its 4.0% Fixed to Floating Rate Subordinated Notes due 2031, reflecting a strong capital position and liqui…

RBB
Patriot Bank Expands High Net Worth Banking Platform in Greenwich, CT
Jun 15, 2026
Derek Hwang
Press Releases

Patriot Bank Expands High Net Worth Banking Platform in Greenwich, CT

Patriot Bank, a subsidiary of Patriot National Bancorp (NASDAQ: PNBK), is expanding its high-net-worth banking platform in Greenwich and Fairfield County, Connecticut. The bank has appointed seasoned private banking executives, including DeWitt Hutchins as Connecticut Market President, and plans to enhance its Mason Street branch with upgraded faci…

PNBK
Splash Beverage Group Invests in Avicanna, a Leading Cannabinoid Biopharmaceutical Platform, Advancing Its Transformation Into Cannabinoid Healthcare
Jun 15, 2026
Caleb Monroe
Press Releases

Splash Beverage Group Invests in Avicanna, a Leading Cannabinoid Biopharmaceutical Platform, Advancing Its Transformation Into Cannabinoid Healthcare

Splash Beverage Group completed a strategic investment of CDN$300,000 in Avicanna Inc., a leading cannabinoid biopharmaceutical company, to support its shift towards a cannabinoid-based health, wellness, and healthcare platform. The investment aligns with Splash's goal to leverage Avicanna's clinical-stage pharmaceutical assets, intellectual proper…

SBEV
Alto Ingredients, Inc. Completes Transaction to Monetize All 2025 45Z Clean Fuel Production Tax Credits
Jun 15, 2026
Avery Klein
Press Releases

Alto Ingredients, Inc. Completes Transaction to Monetize All 2025 45Z Clean Fuel Production Tax Credits

Alto Ingredients, Inc., a US-based producer of specialty alcohols and renewable fuels, completed a sale of its 2025 Section 45Z Clean Fuel Production Tax Credits for approximately $8.9 million in cash. The transaction aligns with the company's strategy to monetize tax credits generated from its low-carbon ethanol production facilities, providing a …

ALTO
Jet.AI Announces New Record Date for Distribution of SpinCo Shares in Connection with Proposed flyExclusive Transaction
Jun 15, 2026
Leila Farooq
Press Releases

Jet.AI Announces New Record Date for Distribution of SpinCo Shares in Connection with Proposed flyExclusive Transaction

Jet.AI Inc. announced June 25, 2026 as the new record date for stockholders eligible to receive shares of SpinCo in connection with its proposed merger with flyExclusive. The transaction is pending stockholder approval, with the special meeting reconvening on June 23, 2026. Proxy advisory firms recommend voting for the deal, but completion remains …

JTAI
Conexeu Expands Board, Executive, and Advisory Leadership With Five Appointments Post Nasdaq Listing
Jun 15, 2026
Marcus Reed
Press Releases

Conexeu Expands Board, Executive, and Advisory Leadership With Five Appointments Post Nasdaq Listing

Conexeu Sciences Inc., a Nasdaq-listed biotechnology company specializing in regenerative tissue therapies, announced five key leadership appointments including additions to its Board of Directors and the naming of a new Chief Commercial Officer. These leadership enhancements aim to strengthen the company's commercial and strategic capabilities as …

CNXU
Cadrenal Therapeutics Advances Multi-Indication Strategy for CAD-1005; Launches Phase 2a Acute Kidney Injury (CSA-AKI) Clinical Plan to Accelerate Pharma Partnering at Upcoming BIO 2026
Jun 15, 2026
Marcus Reed
Press Releases

Cadrenal Therapeutics Advances Multi-Indication Strategy for CAD-1005; Launches Phase 2a Acute Kidney Injury (CSA-AKI) Clinical Plan to Accelerate Pharma Partnering at Upcoming BIO 2026

Cadrenal Therapeutics announced plans to initiate a Phase 2a proof-of-concept clinical trial for its drug candidate CAD-1005, targeting prevention of Acute Kidney Injury (AKI) associated with cardiac surgery (CSA-AKI). This expands the potential application of CAD-1005, which is already in late-stage development for heparin-induced thrombocytopenia…

CVKD
QTREX Quantum’s AME Technology Achieves 97% Yield Validation at One of the Largest U.S. Interconnect Manufacturers
Jun 15, 2026
Marcus Reed
Press Releases

QTREX Quantum’s AME Technology Achieves 97% Yield Validation at One of the Largest U.S. Interconnect Manufacturers

QTREX Quantum Ltd. announced a major production milestone as one of the largest U.S.-based interconnect manufacturers adopted QTREX's Additively Manufactured Electronics (AME) technology for full production after extensive validation, achieving a 97% yield rate. This advancement marks QTREX's readiness for demanding manufacturing environments and s…

QTEX
Aeries Technology Secures Strategic GCC Advisory Mandate with Leading Global Tax and Financial Advisory Platform
Jun 15, 2026
Derek Hwang
Press Releases

Aeries Technology Secures Strategic GCC Advisory Mandate with Leading Global Tax and Financial Advisory Platform

Aeries Technology has secured a strategic advisory engagement from a leading global tax and financial advisory firm to support the expansion of its India-based Global Capability Center (GCC) in a Tier-II city. This reflects a growing corporate trend of expanding GCCs beyond traditional metro areas to leverage deeper talent pools and improved operat…

AERT
Polyrizon Advances NASARIX™ Development with Key Human Study to Characterize Nasal Residence Time and Support FDA Regulatory Pathway
Jun 15, 2026
Leila Farooq
Press Releases

Polyrizon Advances NASARIX™ Development with Key Human Study to Characterize Nasal Residence Time and Support FDA Regulatory Pathway

Polyrizon Ltd. announced a collaboration with a leading European medical center and a clinical research organization to conduct a human study evaluating the nasal residence time of its investigational NASARIX™ (PL-14) Allergy Blocker. This study aims to characterize the formulation's retention in the nasal cavity, aiding in quantifying the duration…

PLRZ
Fiserv Announces Leadership Transition
Jun 15, 2026
Maya Rios
Press Releases

Fiserv Announces Leadership Transition

Fiserv, a global leader in payments and financial services technology, has announced Takis Georgakopoulos as its new CEO following Mike Lyons' departure to Truist Financial. Georgakopoulos brings extensive experience in payments, technology, AI, and cybersecurity. The company reaffirms its 2026 outlook with expected organic revenue growth of 1-3% a…

FISV
Neumora Therapeutics Reports Data from Phase 3 KOASTAL Program and Provides Business and Pipeline Update
Jun 15, 2026
Sofia Navarro
Press Releases

Neumora Therapeutics Reports Data from Phase 3 KOASTAL Program and Provides Business and Pipeline Update

Neumora Therapeutics announced that its Phase 3 KOASTAL-2 and -3 trials of navacaprant for major depressive disorder failed to meet primary and key secondary endpoints. The company will cease development of navacaprant and realign its resources to advance other pipeline programs in Alzheimer's disease agitation, schizophrenia, and cardiometabolic d…

NMRA
AFC Announces Dividend for the Second Quarter 2026
Jun 15, 2026
Nina Shah
Press Releases

AFC Announces Dividend for the Second Quarter 2026

Advanced Flower Capital Inc. announced a quarterly dividend of $0.05 per share for the quarter ending June 30, 2026, payable on July 15, 2026. This dividend matches the payout from the prior quarter, reflecting steady dividend policy from the business development company which provides credit solutions to lower middle-market companies.

AFCG